- Home
- SPWH vs AGEN Comparison
SPWH vs AGEN Comparison
Compare SPWH & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPWH
- AGEN
- Stock Information
- Founded
- SPWH 1986
- AGEN 1994
- Country
- SPWH United States
- AGEN United States
- Employees
- SPWH N/A
- AGEN N/A
- Industry
- SPWH Other Specialty Stores
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPWH Consumer Discretionary
- AGEN Health Care
- Exchange
- SPWH Nasdaq
- AGEN Nasdaq
- Market Cap
- SPWH 111.7M
- AGEN 97.7M
- IPO Year
- SPWH 2014
- AGEN 2000
- Fundamental
- Price
- SPWH $2.88
- AGEN $4.57
- Analyst Decision
- SPWH Buy
- AGEN Buy
- Analyst Count
- SPWH 6
- AGEN 3
- Target Price
- SPWH $3.00
- AGEN $10.00
- AVG Volume (30 Days)
- SPWH 386.0K
- AGEN 399.7K
- Earning Date
- SPWH 12-04-2024
- AGEN 11-05-2024
- Dividend Yield
- SPWH N/A
- AGEN N/A
- EPS Growth
- SPWH N/A
- AGEN N/A
- EPS
- SPWH N/A
- AGEN N/A
- Revenue
- SPWH $1,243,937,000.00
- AGEN $159,630,000.00
- Revenue This Year
- SPWH N/A
- AGEN N/A
- Revenue Next Year
- SPWH $0.68
- AGEN $0.04
- P/E Ratio
- SPWH N/A
- AGEN N/A
- Revenue Growth
- SPWH N/A
- AGEN 60.67
- 52 Week Low
- SPWH $1.81
- AGEN $4.18
- 52 Week High
- SPWH $5.55
- AGEN $21.20
- Technical
- Relative Strength Index (RSI)
- SPWH 54.01
- AGEN 41.14
- Support Level
- SPWH $2.70
- AGEN $4.50
- Resistance Level
- SPWH $2.97
- AGEN $4.91
- Average True Range (ATR)
- SPWH 0.21
- AGEN 0.32
- MACD
- SPWH -0.02
- AGEN 0.02
- Stochastic Oscillator
- SPWH 77.65
- AGEN 23.93
About SPWH Sportsman's Warehouse Holdings Inc.
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).